Climb Bio director granted 40,000 stock options
Climb Bio director Thomas Stephen Basil received a grant of stock options covering 40,000 shares of common stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Climb Bio director Thomas Stephen Basil received a grant of stock options covering 40,000 shares of common stock. The options have an exercise price of $10.55 per share and expire on June 4, 2036.
The options will vest on the earlier of June 5, 2027, or immediately before the next annual meeting of stockholders, as long as he continues to serve through that date.
Insider Trade Summary
Grant/Award: 40,000 shares
Grant/Award
1 txn
Insider
Thomas Stephen Basil
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 40,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 40,000 contracts (Direct)
Footnotes (1)
- F1. The shares subject to the option will vest on the earlier of June 5, 2027 or the date immediately prior to the date of the next annual meeting of stockholders, subject to the reporting person's continued service through such date.
Key Figures
Option grant size: 40,000 options
Exercise price: $10.55 per share
Shares underlying options: 40,000 shares
+3 more
6 metrics
Option grant size
40,000 options
Stock Option (Right to Buy) covering common stock
Exercise price
$10.55 per share
Exercise price for the stock options
Shares underlying options
40,000 shares
Underlying common stock for the option award
Expiration date
June 4, 2036
Option expiration date
Vesting date trigger
June 5, 2027
Latest vesting date, or earlier before next annual meeting
Shares after transaction
40,000 derivative securities
Total options held after this grant
Key Terms
Stock Option (Right to Buy), exercise price, Common Stock, vest, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "10.5500""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
vest financial
"The shares subject to the option will vest on the earlier of June 5, 2027"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
annual meeting of stockholders financial
"or the date immediately prior to the date of the next annual meeting of stockholders"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Climb Bio (CLYM) director Thomas Stephen Basil receive in this Form 4?
Thomas Stephen Basil received a grant of stock options for 40,000 Climb Bio shares. These options give him the right to buy common stock at a fixed exercise price, as part of his director compensation arrangement.
What is the exercise price of Thomas Stephen Basil’s Climb Bio stock options?
The stock options have an exercise price of $10.55 per share. This means he can purchase Climb Bio common stock at $10.55 regardless of the market price once the options have vested and before they expire.
When do Thomas Stephen Basil’s Climb Bio stock options vest?
The options vest on the earlier of June 5, 2027, or immediately before Climb Bio’s next annual stockholder meeting. Vesting is conditioned on his continued service as a director through the applicable vesting date specified in the grant.
When do the Climb Bio stock options granted to Thomas Stephen Basil expire?
The options expire on June 4, 2036. After that expiration date, he can no longer exercise them to purchase Climb Bio common stock, even if some or all of the options had previously vested under the grant terms.
AI-generated analysis. How Rhea-AI works. Not financial advice.
